Lansoprazole
| Grade | Pharmaceutical |
| Pharmacopoeia | BP |
| CAS No. | 103577-45-3 |
| Product Name | Lansoprazole |
| Chemical Name | 2-[(RS)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole |
| Function | Active Pharmaceutical Ingredients (APIs) |
| Industrial Application | Pharmaceutical |
| Category | Proton pump inhibitor |
General Description
Lansoprazole is a proton pump inhibitor used to reduce gastric acid production. It is commonly prescribed to treat gastroesophageal reflux disease (GERD), peptic ulcer disease, Zollinger-Ellison syndrome, and other conditions involving excessive stomach acid. It allows the esophagus to heal and prevents further damage.
Physical Characteristics
| Molecular formula | C16H14F3N3O2S |
| Molecular weight | 369.4 |
| Appearance | White or brownish powder |
| Solubility | Practically insoluble in water, soluble in anhydrous ethanol, very slightly soluble in acetonitrile |
| Water | Maximum 0.1% |
| Sulfated ash | Maximum 0.1% |
| Purity | Minimum 99.4% |
| Assay | 99.0% to 101.0% (anhydrous substance) |
| Storage</t |